Literature DB >> 7721871

Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat 5.

T J Wood1, D Sliva, P E Lobie, T J Pircher, F Gouilleux, H Wakao, J A Gustafsson, B Groner, G Norstedt, L A Haldosén.   

Abstract

Previous observations have shown that binding of growth hormone to its receptor leads to activation of transcription factors via a mechanism involving phosphorylation on tyrosine residues. In order to establish whether the prolactin-activated transcription factor Stat 5 (mammary gland factor) is also activated by growth hormone, nuclear extracts were prepared from COS-7 cells transiently expressing transfected Stat 5 and growth hormone receptor cDNA. Gel electrophoresis mobility shift analyses revealed the growth hormone-dependent presence of specific DNA-binding proteins in these extracts. The complexes formed could be supershifted by polyclonal anti-Stat 5 antiserum. In other experiments nuclear extracts from growth hormone-treated Chinese hamster ovary cells stably expressing transfected growth hormone receptor cDNA and liver from growth hormone-treated hypophysectomized rats were used for gel electrophoresis mobility shift analyses. These also revealed the presence of specific DNA-binding proteins sharing antigenic determinants with Stat 5. Stat 5 cDNA was shown to be capable of complementing the growth hormone-dependent activation of transcription of a reporter gene in the otherwise unresponsive COS-7 cell line. This complementation was dependent on the presence of Stat 5 tyrosine 694, suggesting a role for phosphorylation of this residue in growth hormone-dependent activation of DNA-binding and transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7721871     DOI: 10.1074/jbc.270.16.9448

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

2.  Enhanced hematopoietic differentiation of embryonic stem cells conditionally expressing Stat5.

Authors:  Michael Kyba; Rita C R Perlingeiro; Russell R Hoover; Chi-Wei Lu; Jonathan Pierce; George Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

3.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

4.  Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex.

Authors:  Y R Boisclair; D Seto; S Hsieh; K R Hurst; G T Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

Review 5.  The role of Jak/STAT signaling in heart tissue renin-angiotensin system.

Authors:  E Mascareno; M A Siddiqui
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

6.  A STAT factor mediates the sexually dimorphic regulation of hepatic cytochrome P450 3A10/lithocholic acid 6 beta-hydroxylase gene expression by growth hormone.

Authors:  A Subramanian; J Teixeira; J Wang; G Gil
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

7.  Dispersed Chromosomal Stat5b-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription.

Authors:  Dennis J Chia; Ben Varco-Merth; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

8.  Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

Authors:  R Moriggl; V Gouilleux-Gruart; R Jähne; S Berchtold; C Gartmann; X Liu; L Hennighausen; A Sotiropoulos; B Groner; F Gouilleux
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  Reaction-diffusion modeling ERK- and STAT-interaction dynamics.

Authors:  Nikola Georgiev; Valko Petrov; Georgi Georgiev
Journal:  EURASIP J Bioinform Syst Biol       Date:  2006

10.  Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation.

Authors:  Atsushi Hosui; Akiko Kimura; Daisuke Yamaji; Bing-mei Zhu; Risu Na; Lothar Hennighausen
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.